粘膜黒色腫治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Mucosal Melanoma Treatment Market Insights, Forecast to 2028

• レポートコード：QY2203B13142
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、112ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の粘膜黒色腫治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に粘膜黒色腫治療の世界市場のxxx％を占める「外科的切除」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の粘膜黒色腫治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの粘膜黒色腫治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの粘膜黒色腫治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

粘膜黒色腫治療のグローバル主要メーカーには、Roche、Novartis AG、Merck、Bristol-Myers Squibb、Amgen、Takeda Pharmaceutical Company、Polynoma、Reliance Life Sciences、Avax Technologies、AstraZeneca、Biogen Idec、GSK、Pfizer、Eisai、Sanofi、Genetechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

粘膜黒色腫治療市場は、種類と用途によって区分されます。世界の粘膜黒色腫治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
外科的切除、化学療法、免疫療法、標的治療

【用途別セグメント】
病院薬局、小売薬局、オンラインショップ

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 粘膜黒色腫治療製品概要
- 種類別市場（外科的切除、化学療法、免疫療法、標的治療）
- 用途別市場（病院薬局、小売薬局、オンラインショップ）
- 調査の目的
・エグゼクティブサマリー
- 世界の粘膜黒色腫治療販売量予測2017-2028
- 世界の粘膜黒色腫治療売上予測2017-2028
- 粘膜黒色腫治療の地域別販売量
- 粘膜黒色腫治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別粘膜黒色腫治療販売量
- 主要メーカー別粘膜黒色腫治療売上
- 主要メーカー別粘膜黒色腫治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（外科的切除、化学療法、免疫療法、標的治療）
- 粘膜黒色腫治療の種類別販売量
- 粘膜黒色腫治療の種類別売上
- 粘膜黒色腫治療の種類別価格
・用途別市場規模（病院薬局、小売薬局、オンラインショップ）
- 粘膜黒色腫治療の用途別販売量
- 粘膜黒色腫治療の用途別売上
- 粘膜黒色腫治療の用途別価格
・北米市場
- 北米の粘膜黒色腫治療市場規模（種類別、用途別）
- 主要国別の粘膜黒色腫治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの粘膜黒色腫治療市場規模（種類別、用途別）
- 主要国別の粘膜黒色腫治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の粘膜黒色腫治療市場規模（種類別、用途別）
- 主要国別の粘膜黒色腫治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の粘膜黒色腫治療市場規模（種類別、用途別）
- 主要国別の粘膜黒色腫治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの粘膜黒色腫治療市場規模（種類別、用途別）
- 主要国別の粘膜黒色腫治療市場規模（トルコ、サウジアラビア）
・企業情報
Roche、Novartis AG、Merck、Bristol-Myers Squibb、Amgen、Takeda Pharmaceutical Company、Polynoma、Reliance Life Sciences、Avax Technologies、AstraZeneca、Biogen Idec、GSK、Pfizer、Eisai、Sanofi、Genetech
・産業チェーン及び販売チャネル分析
- 粘膜黒色腫治療の産業チェーン分析
- 粘膜黒色腫治療の原材料
- 粘膜黒色腫治療の生産プロセス
- 粘膜黒色腫治療の販売及びマーケティング
- 粘膜黒色腫治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 粘膜黒色腫治療の産業動向
- 粘膜黒色腫治療のマーケットドライバー
- 粘膜黒色腫治療の課題
- 粘膜黒色腫治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Mucosal Melanoma Treatment Market
The global Mucosal Melanoma Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Surgical Resection accounting for % of the Mucosal Melanoma Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
China Mucosal Melanoma Treatment market size is valued at US$ million in 2021, while the North America and Europe Mucosal Melanoma Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mucosal Melanoma Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mucosal Melanoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mucosal Melanoma Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mucosal Melanoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mucosal Melanoma Treatment market.
Global Mucosal Melanoma Treatment Scope and Market Size
Mucosal Melanoma Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Mucosal Melanoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Surgical Resection
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Stores
By Company
Roche
Novartis AG
Merck
Bristol-Myers Squibb
Amgen
Takeda Pharmaceutical Company
Polynoma
Reliance Life Sciences
Avax Technologies
AstraZeneca
Biogen Idec
GSK
Pfizer
Eisai
Sanofi
Genetech
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucosal Melanoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Surgical Resection
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Mucosal Melanoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Stores
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mucosal Melanoma Treatment Market Perspective (2017-2028)
2.2 Mucosal Melanoma Treatment Growth Trends by Region
2.2.1 Mucosal Melanoma Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mucosal Melanoma Treatment Historic Market Size by Region (2017-2022)
2.2.3 Mucosal Melanoma Treatment Forecasted Market Size by Region (2023-2028)
2.3 Mucosal Melanoma Treatment Market Dynamics
2.3.1 Mucosal Melanoma Treatment Industry Trends
2.3.2 Mucosal Melanoma Treatment Market Drivers
2.3.3 Mucosal Melanoma Treatment Market Challenges
2.3.4 Mucosal Melanoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mucosal Melanoma Treatment Players by Revenue
3.1.1 Global Top Mucosal Melanoma Treatment Players by Revenue (2017-2022)
3.1.2 Global Mucosal Melanoma Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Mucosal Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mucosal Melanoma Treatment Revenue
3.4 Global Mucosal Melanoma Treatment Market Concentration Ratio
3.4.1 Global Mucosal Melanoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucosal Melanoma Treatment Revenue in 2021
3.5 Mucosal Melanoma Treatment Key Players Head office and Area Served
3.6 Key Players Mucosal Melanoma Treatment Product Solution and Service
3.7 Date of Enter into Mucosal Melanoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucosal Melanoma Treatment Breakdown Data by Type
4.1 Global Mucosal Melanoma Treatment Historic Market Size by Type (2017-2022)
4.2 Global Mucosal Melanoma Treatment Forecasted Market Size by Type (2023-2028)
5 Mucosal Melanoma Treatment Breakdown Data by Application
5.1 Global Mucosal Melanoma Treatment Historic Market Size by Application (2017-2022)
5.2 Global Mucosal Melanoma Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mucosal Melanoma Treatment Market Size (2017-2028)
6.2 North America Mucosal Melanoma Treatment Market Size by Type
6.2.1 North America Mucosal Melanoma Treatment Market Size by Type (2017-2022)
6.2.2 North America Mucosal Melanoma Treatment Market Size by Type (2023-2028)
6.2.3 North America Mucosal Melanoma Treatment Market Share by Type (2017-2028)
6.3 North America Mucosal Melanoma Treatment Market Size by Application
6.3.1 North America Mucosal Melanoma Treatment Market Size by Application (2017-2022)
6.3.2 North America Mucosal Melanoma Treatment Market Size by Application (2023-2028)
6.3.3 North America Mucosal Melanoma Treatment Market Share by Application (2017-2028)
6.4 North America Mucosal Melanoma Treatment Market Size by Country
6.4.1 North America Mucosal Melanoma Treatment Market Size by Country (2017-2022)
6.4.2 North America Mucosal Melanoma Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Mucosal Melanoma Treatment Market Size (2017-2028)
7.2 Europe Mucosal Melanoma Treatment Market Size by Type
7.2.1 Europe Mucosal Melanoma Treatment Market Size by Type (2017-2022)
7.2.2 Europe Mucosal Melanoma Treatment Market Size by Type (2023-2028)
7.2.3 Europe Mucosal Melanoma Treatment Market Share by Type (2017-2028)
7.3 Europe Mucosal Melanoma Treatment Market Size by Application
7.3.1 Europe Mucosal Melanoma Treatment Market Size by Application (2017-2022)
7.3.2 Europe Mucosal Melanoma Treatment Market Size by Application (2023-2028)
7.3.3 Europe Mucosal Melanoma Treatment Market Share by Application (2017-2028)
7.4 Europe Mucosal Melanoma Treatment Market Size by Country
7.4.1 Europe Mucosal Melanoma Treatment Market Size by Country (2017-2022)
7.4.2 Europe Mucosal Melanoma Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mucosal Melanoma Treatment Market Size (2017-2028)
8.2 Asia-Pacific Mucosal Melanoma Treatment Market Size by Type
8.2.1 Asia-Pacific Mucosal Melanoma Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Mucosal Melanoma Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Mucosal Melanoma Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Mucosal Melanoma Treatment Market Size by Application
8.3.1 Asia-Pacific Mucosal Melanoma Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Mucosal Melanoma Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Mucosal Melanoma Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Mucosal Melanoma Treatment Market Size by Region
8.4.1 Asia-Pacific Mucosal Melanoma Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Mucosal Melanoma Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Mucosal Melanoma Treatment Market Size (2017-2028)
9.2 Latin America Mucosal Melanoma Treatment Market Size by Type
9.2.1 Latin America Mucosal Melanoma Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Mucosal Melanoma Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Mucosal Melanoma Treatment Market Share by Type (2017-2028)
9.3 Latin America Mucosal Melanoma Treatment Market Size by Application
9.3.1 Latin America Mucosal Melanoma Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Mucosal Melanoma Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Mucosal Melanoma Treatment Market Share by Application (2017-2028)
9.4 Latin America Mucosal Melanoma Treatment Market Size by Country
9.4.1 Latin America Mucosal Melanoma Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Mucosal Melanoma Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mucosal Melanoma Treatment Market Size (2017-2028)
10.2 Middle East & Africa Mucosal Melanoma Treatment Market Size by Type
10.2.1 Middle East & Africa Mucosal Melanoma Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Mucosal Melanoma Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Mucosal Melanoma Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Mucosal Melanoma Treatment Market Size by Application
10.3.1 Middle East & Africa Mucosal Melanoma Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Mucosal Melanoma Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Mucosal Melanoma Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Mucosal Melanoma Treatment Market Size by Country
10.4.1 Middle East & Africa Mucosal Melanoma Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Mucosal Melanoma Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Mucosal Melanoma Treatment Introduction
11.1.4 Roche Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Mucosal Melanoma Treatment Introduction
11.2.4 Novartis AG Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.2.5 Novartis AG Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Mucosal Melanoma Treatment Introduction
11.3.4 Merck Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Mucosal Melanoma Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Mucosal Melanoma Treatment Introduction
11.5.4 Amgen Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.5.5 Amgen Recent Developments
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Details
11.6.2 Takeda Pharmaceutical Company Business Overview
11.6.3 Takeda Pharmaceutical Company Mucosal Melanoma Treatment Introduction
11.6.4 Takeda Pharmaceutical Company Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.6.5 Takeda Pharmaceutical Company Recent Developments
11.7 Polynoma
11.7.1 Polynoma Company Details
11.7.2 Polynoma Business Overview
11.7.3 Polynoma Mucosal Melanoma Treatment Introduction
11.7.4 Polynoma Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.7.5 Polynoma Recent Developments
11.8 Reliance Life Sciences
11.8.1 Reliance Life Sciences Company Details
11.8.2 Reliance Life Sciences Business Overview
11.8.3 Reliance Life Sciences Mucosal Melanoma Treatment Introduction
11.8.4 Reliance Life Sciences Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.8.5 Reliance Life Sciences Recent Developments
11.9 Avax Technologies
11.9.1 Avax Technologies Company Details
11.9.2 Avax Technologies Business Overview
11.9.3 Avax Technologies Mucosal Melanoma Treatment Introduction
11.9.4 Avax Technologies Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.9.5 Avax Technologies Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Mucosal Melanoma Treatment Introduction
11.10.4 AstraZeneca Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.10.5 AstraZeneca Recent Developments
11.11 Biogen Idec
11.11.1 Biogen Idec Company Details
11.11.2 Biogen Idec Business Overview
11.11.3 Biogen Idec Mucosal Melanoma Treatment Introduction
11.11.4 Biogen Idec Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.11.5 Biogen Idec Recent Developments
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Mucosal Melanoma Treatment Introduction
11.12.4 GSK Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.12.5 GSK Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Mucosal Melanoma Treatment Introduction
11.13.4 Pfizer Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.13.5 Pfizer Recent Developments
11.14 Eisai
11.14.1 Eisai Company Details
11.14.2 Eisai Business Overview
11.14.3 Eisai Mucosal Melanoma Treatment Introduction
11.14.4 Eisai Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.14.5 Eisai Recent Developments
11.15 Sanofi
11.15.1 Sanofi Company Details
11.15.2 Sanofi Business Overview
11.15.3 Sanofi Mucosal Melanoma Treatment Introduction
11.15.4 Sanofi Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.15.5 Sanofi Recent Developments
11.16 Genetech
11.16.1 Genetech Company Details
11.16.2 Genetech Business Overview
11.16.3 Genetech Mucosal Melanoma Treatment Introduction
11.16.4 Genetech Revenue in Mucosal Melanoma Treatment Business (2017-2022)
11.16.5 Genetech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Mucosal Melanoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Surgical Resection
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Targeted Therapy
Table 6. Global Mucosal Melanoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Mucosal Melanoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Mucosal Melanoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Mucosal Melanoma Treatment Market Share by Region (2017-2022)
Table 10. Global Mucosal Melanoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Mucosal Melanoma Treatment Market Share by Region (2023-2028)
Table 12. Mucosal Melanoma Treatment Market Trends
Table 13. Mucosal Melanoma Treatment Market Drivers
Table 14. Mucosal Melanoma Treatment Market Challenges
Table 15. Mucosal Melanoma Treatment Market Restraints
Table 16. Global Mucosal Melanoma Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Mucosal Melanoma Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Mucosal Melanoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucosal Melanoma Treatment as of 2021)
Table 19. Ranking of Global Top Mucosal Melanoma Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Mucosal Melanoma Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mucosal Melanoma Treatment Product Solution and Service
Table 23. Date of Enter into Mucosal Melanoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Mucosal Melanoma Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Mucosal Melanoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Mucosal Melanoma Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Mucosal Melanoma Treatment Revenue Share by Application (2017-2022)
Table 31. Global Mucosal Melanoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Mucosal Melanoma Treatment Revenue Share by Application (2023-2028)
Table 33. North America Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Mucosal Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Mucosal Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Mucosal Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Mucosal Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Mucosal Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Mucosal Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Mucosal Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Mucosal Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Mucosal Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Mucosal Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Mucosal Melanoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Mucosal Melanoma Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Mucosal Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Mucosal Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Mucosal Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Mucosal Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Mucosal Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Mucosal Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Mucosal Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Mucosal Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Mucosal Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Mucosal Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Mucosal Melanoma Treatment Product
Table 66. Roche Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 67. Roche Recent Developments
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Mucosal Melanoma Treatment Product
Table 71. Novartis AG Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 72. Novartis AG Recent Developments
Table 73. Merck Company Details
Table 74. Merck Business Overview
Table 75. Merck Mucosal Melanoma Treatment Product
Table 76. Merck Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 77. Merck Recent Developments
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Mucosal Melanoma Treatment Product
Table 81. Bristol-Myers Squibb Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Developments
Table 83. Amgen Company Details
Table 84. Amgen Business Overview
Table 85. Amgen Mucosal Melanoma Treatment Product
Table 86. Amgen Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 87. Amgen Recent Developments
Table 88. Takeda Pharmaceutical Company Company Details
Table 89. Takeda Pharmaceutical Company Business Overview
Table 90. Takeda Pharmaceutical Company Mucosal Melanoma Treatment Product
Table 91. Takeda Pharmaceutical Company Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 92. Takeda Pharmaceutical Company Recent Developments
Table 93. Polynoma Company Details
Table 94. Polynoma Business Overview
Table 95. Polynoma Mucosal Melanoma Treatment Product
Table 96. Polynoma Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 97. Polynoma Recent Developments
Table 98. Reliance Life Sciences Company Details
Table 99. Reliance Life Sciences Business Overview
Table 100. Reliance Life Sciences Mucosal Melanoma Treatment Product
Table 101. Reliance Life Sciences Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 102. Reliance Life Sciences Recent Developments
Table 103. Avax Technologies Company Details
Table 104. Avax Technologies Business Overview
Table 105. Avax Technologies Mucosal Melanoma Treatment Product
Table 106. Avax Technologies Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 107. Avax Technologies Recent Developments
Table 108. AstraZeneca Company Details
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Mucosal Melanoma Treatment Product
Table 111. AstraZeneca Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 112. AstraZeneca Recent Developments
Table 113. Biogen Idec Company Details
Table 114. Biogen Idec Business Overview
Table 115. Biogen Idec Mucosal Melanoma Treatment Product
Table 116. Biogen Idec Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 117. Biogen Idec Recent Developments
Table 118. GSK Company Details
Table 119. GSK Business Overview
Table 120. GSK Mucosal Melanoma Treatment Product
Table 121. GSK Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 122. GSK Recent Developments
Table 123. Pfizer Company Details
Table 124. Pfizer Business Overview
Table 125. Pfizer Mucosal Melanoma Treatment Product
Table 126. Pfizer Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 127. Pfizer Recent Developments
Table 128. Eisai Company Details
Table 129. Eisai Business Overview
Table 130. Eisai Mucosal Melanoma Treatment Product
Table 131. Eisai Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 132. Eisai Recent Developments
Table 133. Sanofi Company Details
Table 134. Sanofi Business Overview
Table 135. Sanofi Mucosal Melanoma Treatment Product
Table 136. Sanofi Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 137. Sanofi Recent Developments
Table 138. Genetech Company Details
Table 139. Genetech Business Overview
Table 140. Genetech Mucosal Melanoma Treatment Product
Table 141. Genetech Revenue in Mucosal Melanoma Treatment Business (2017-2022) & (US$ Million)
Table 142. Genetech Recent Developments
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucosal Melanoma Treatment Market Share by Type: 2021 VS 2028
Figure 2. Surgical Resection Features
Figure 3. Chemotherapy Features
Figure 4. Immunotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Global Mucosal Melanoma Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Stores Case Studies
Figure 10. Mucosal Melanoma Treatment Report Years Considered
Figure 11. Global Mucosal Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Mucosal Melanoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Mucosal Melanoma Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Mucosal Melanoma Treatment Market Share by Players in 2021
Figure 15. Global Top Mucosal Melanoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucosal Melanoma Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Mucosal Melanoma Treatment Revenue in 2021
Figure 17. North America Mucosal Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Mucosal Melanoma Treatment Market Size Market Share by Type (2017-2028)
Figure 19. North America Mucosal Melanoma Treatment Market Size Market Share by Application (2017-2028)
Figure 20. North America Mucosal Melanoma Treatment Market Size Share by Country (2017-2028)
Figure 21. United States Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Mucosal Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Mucosal Melanoma Treatment Market Size Market Share by Type (2017-2028)
Figure 25. Europe Mucosal Melanoma Treatment Market Size Market Share by Application (2017-2028)
Figure 26. Europe Mucosal Melanoma Treatment Market Size Share by Country (2017-2028)
Figure 27. Germany Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Mucosal Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Mucosal Melanoma Treatment Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Mucosal Melanoma Treatment Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Mucosal Melanoma Treatment Market Size Share by Region (2017-2028)
Figure 37. China Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Mucosal Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Mucosal Melanoma Treatment Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Mucosal Melanoma Treatment Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Mucosal Melanoma Treatment Market Size Share by Country (2017-2028)
Figure 47. Mexico Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Mucosal Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Mucosal Melanoma Treatment Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Mucosal Melanoma Treatment Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Mucosal Melanoma Treatment Market Size Share by Country (2017-2028)
Figure 53. Turkey Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Mucosal Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 57. Novartis AG Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 58. Merck Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 60. Amgen Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 61. Takeda Pharmaceutical Company Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 62. Polynoma Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 63. Reliance Life Sciences Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 64. Avax Technologies Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 65. AstraZeneca Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 66. Biogen Idec Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 67. GSK Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 68. Pfizer Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 69. Eisai Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 70. Sanofi Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 71. Genetech Revenue Growth Rate in Mucosal Melanoma Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

皮膚剥離症治療薬のグローバル市場インサイト・予測（～2028年）

Global Cutaneous Fribrosis Treatment Market Insights and Forecast to 2028
QY2203B13371 2022年3月 89Pages
新型コロナウイルス感染症のパンデミックにより、世界の皮膚剥離症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に皮膚剥離症治療薬の世...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

CO2回収プラントのグローバル市場インサイト・予測（～2028年）

Global CO2 Recovery Plant Market Insights, Forecast to 2028
QY2203B00478 2022年3月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のCO2回収プラントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にCO2回収プラント...

GaNウェーハ用CMPパッド（GaN基板）のグローバル市場インサイト・予測（～2028年）

Global CMP Pads for GaN Wafer (GaN Substrate) Market Insights, Forecast to 2028
QY2203B00612 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のGaNウェーハ用CMPパッド（GaN基板）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

輪状甲状腺切開術シミュレーターのグローバル市場インサイト・予測（～2028年）

Global Cricothyrotomy Simulators Market Insights and Forecast to 2028
QY2203B14244 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の輪状甲状腺切開術シミュレーターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に輪状甲...

ジブチルアミン(DBA)のグローバル市場インサイト・予測（～2028年）

Global Dibutylamine(DBA)(CAS 111-92-2) Market Insights and Forecast to 2028
QY2203B03170 2022年3月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界のジブチルアミン(DBA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジブチルアミ...

N-エチルメタベースエステルのグローバル市場インサイト・予測（～2028年）

Global N-Ethyl Meta Base Ester Market Insights and Forecast to 2028
QY2203B00893 2022年3月 71Pages
新型コロナウイルス感染症のパンデミックにより、世界のN-エチルメタベースエステルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN-エチ...

医療用PFAのグローバル市場インサイト・予測（～2028年）

Global Medical Grade PFA Market Insights, Forecast to 2028
QY2203B07478 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の医療用PFAの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用PFAの世界市場の...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年） Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device. Ma…
皮膚剥離症治療薬のグローバル市場インサイト・予測（～2028年） Cutaneous Fribrosis Treatment refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs. Market Analysis and Insights: Global Cutaneous Fribrosis Treatment Market Due to the COVID-19 pandemic, the global Cutaneous Fribrosis Treatment…
パルスチェイス解析のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Pulse-chase Analysis Market The global Pulse-chase Analysis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Polychromatic Pulse Tracing …
CO2回収プラントのグローバル市場インサイト・予測（～2028年） The working principle of CO2 Recovery Plant is to first cool the exhaust gas of factories, etc., and then pass it into a liquid containing ammonia compounds to adsorb carbon dioxide. The liquid is then heated to complete the separation and recovery of carbon dioxide. Market Analysis and Insights: Gl…
サージカルウエアのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Surgical Wear Market Due to the COVID-19 pandemic, the global Surgical Wear market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the econo…